Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

GSK hands new chief digital officer a transformative remit

Karenann Terrell will join the pharma firm from Walmart

GlaxoSmithKline GSK

GlaxoSmithKline has created a new chief digital and technology officer role as it seeks to transform how new technologies are used to improve the entire group’s performance.

The role will be filed by Karenann Terrell, who will join the pharma firm on 4 September and take up a seat on its Corporate Executive Team.

Emma Walmsley, GSK’s chief executive officer, said: “The impact of technology on the healthcare industry is accelerating and requires us to rethink our approach.

“As a member of the Executive Team, Karenann will have the scope to think radically about how we can exploit the latest opportunities and ultimately improve our business performance.”

GSK has consistently been active in the digital space, most recently looking to apply artificial intelligence to drug discover, targeting COPD adherence with sensor technology and rolling out its first medical device mobile app. However, new CEO Walmsley clearly wants more to be done when it comes to the bigger picture of applying digital technologies.

Terrell previously spent six years as chief information officer for Walmart, where she led a multi-year effort to transform the US retail giant’s use of data, analytics and digital customer engagement.

She will also bring pharma experience to the role, having spent four years before her time at Walmart serving as chief information officer for Baxter International.

In this new role at GSK, Terrell will be responsible for developing GSK’s digital, data and analytics strategy and will work with a wide range of partners from inside and outside the healthcare sector to bring new technologies to GSK.

Her aim will be to enhance areas such as clinical trials and drug development and improve the way GSK interacts with healthcare professionals, customers and consumers, as well as making internal processes more efficient.

Commenting on Terrell’s appointment last week GSK’s CEO Emma Walmsley said she would be “a key partner to accelerate and modernise our capabilities here”.

31st July 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....